IP Explained: Intellectual property system working to combat COVID-19

Biopharmaceutical companies areworking around the clock to research and develop COVID-19 vaccines and treatments. Intellectual property (IP) has enabled robust research collaboration among biopharmaceutical companies, universities and governments and rapid progress on nearly400 potential coronavirus treatments and vaccines with more than 1,020 clinical trials under way.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Patents Intellectual Property IP Explained Coronavirus Source Type: news